Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Dec 17;12(12):e232783.
doi: 10.1136/bcr-2019-232783.

Severe hyperandrogenism due to ovarian hyperthecosis in a young woman

Affiliations
Case Reports

Severe hyperandrogenism due to ovarian hyperthecosis in a young woman

Alpesh Goyal et al. BMJ Case Rep. .

Abstract

Hyperandrogenism is a relatively common clinical problem. However, severe hyperandrogenism causing virilisation is rare. A 27-year-old woman presented with generalised hirsutism, clitoromegaly, breast atrophy and secondary amenorrhoea. She had serum testosterone levels elevated to the adult male range. Administration of gonadotropin-releasing hormone (GnRH) analogue resulted in >50% suppression of serum testosterone which was suggestive of luteinising hormone-dependent ovarian hyperandrogenism. Imaging studies of abdomen and pelvis were normal, and ovarian venous sampling failed to show a gradient between the two sides. A presumptive diagnosis of ovarian hyperthecosis was, therefore, considered. Medical treatment with GnRH analogue and combined oral contraceptive pills was initiated to which an excellent clinical and biochemical response was noted. This case highlights a rare presentation of ovarian hyperthecosis in a young woman with severe hyperandrogenism mimicking a virilising neoplasm.

Keywords: endocrinology; reproductive medicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Yildiz BO. Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab 2006;20:167–76. 10.1016/j.beem.2006.02.004 - DOI - PubMed
    1. Practice Committee of the American Society for Reproductive Medicine The evaluation and treatment of androgen excess. Fertil Steril 2006;86:S241–7. 10.1016/j.fertnstert.2006.08.042 - DOI - PubMed
    1. Mamoojee Y, Ganguri M, Taylor N, et al. . Clinical case seminar: postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis. Clin Endocrinol 2018;88:13–20. 10.1111/cen.13492 - DOI - PubMed
    1. Marcondes JAM, Curi DDG, Matsuzaki CN, et al. . Ovarian hyperthecosis in the context of an adrenal incidentaloma in a postmenopausal woman. Arq Bras Endocrinol Metab 2008;52:1184–8. 10.1590/S0004-27302008000700016 - DOI - PubMed
    1. Meek CL, Bravis V, Don A, et al. . Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism. Obstet Gynecol 2013;15:171–6. 10.1111/tog.12030 - DOI

Publication types